You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Early Peanut Immunotherapy in Children (EPIC) trial: protocol for a pragmatic randomised controlled trial of peanut oral immunotherapy in children under 5 years of age

Article info

Article menu

Download PDFPDF

Protocol
Early Peanut Immunotherapy in Children (EPIC) trial: protocol for a pragmatic randomised controlled trial of peanut oral immunotherapy in children under 5 years of age

Authors

  • Michael David O'Sullivan Immunology Department, Perth Children's Hospital, Nedlands, Western Australia, AustraliaThe University of Western Australia, Perth, Western Australia, AustraliaTelethon Kids Institute, Nedlands, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Natasha Bear Immunology Department, Perth Children's Hospital, Nedlands, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Jessica Metcalfe Immunology Department, Perth Children's Hospital, Nedlands, Western Australia, AustraliaTelethon Kids Institute, Nedlands, Western Australia, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Michael David O'Sullivan; michael.osullivan{at}research.uwa.edu.au
View Full Text

Citation

O'Sullivan MD, Bear N, Metcalfe J
Early Peanut Immunotherapy in Children (EPIC) trial: protocol for a pragmatic randomised controlled trial of peanut oral immunotherapy in children under 5 years of age
BMJ Paediatrics Open 2023;7:e002294. doi: 10.1136/bmjpo-2023-002294

Publication history

  • Received September 21, 2023
  • Accepted October 12, 2023
  • First published November 14, 2023.
Online issue publication 
November 14, 2023
Previous versions
Review history

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.